Product Program year 2025 Source: CMS Open Payments

Denali Vena Cava Filter

Device Vascular/Oncology

PDI 00801741040801

Open in the dashboard

General payments

$65,724

651 payments

Research payments

$0

0 payments

Through program year 2025, $65,724 in general payments and $0 in research payments were reported against Denali Vena Cava Filter (Vascular/Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $12,196 320
2024 General $50,918 274
2023 General $2,609 57

Breakdown

Who paid General payments · program years 2023–2025
  1. C. R. Bard, Inc. & Subsidiaries $40,345 1 payment
  2. Bard Peripheral Vascular, Inc. $21,205 519 payments
  3. Becton, Dickinson and Company $4,021 127 payments
  4. Davol Inc. $154 4 payments
Top recipients General payments · program year 2025
  1. Hosam Attaya Diagnostic Radiology · Newport News, VA $1,112 9% · 2 payments
  2. John Park Vascular Surgery · Omaha, NE $532 4% · 1 payment
  3. Scott Trerotola Vascular & Interventional Radiology · Philadelphia, PA $402 3% · 3 payments
  4. Preston Hood Vascular & Interventional Radiology · Jacksonville, FL $399 3% · 16 payments
  5. Josey Barmore Physician Assistant · Jacksonville, FL $316 3% · 14 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular & Interventional Radiology Radiology $4,584 38% · 82 practitioners
  2. Diagnostic Radiology Radiology $2,831 24% · 34 practitioners
  3. Vascular Surgery Surgery $1,572 13% · 38 practitioners
  4. Physician Assistant $1,002 8% · 23 practitioners
  5. Internal Medicine $421 4% · 6 practitioners

The top 5 of 20 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $2,364 19% · 39 recipients
  2. Texas $1,278 10% · 7 recipients
  3. New York $1,150 9% · 22 recipients
  4. Ohio $1,054 9% · 14 recipients
  5. California $861 7% · 19 recipients

The top 5 of 33 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

651 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record